Paxman AB (PAX) - Total Liabilities
Based on the latest financial reports, Paxman AB (PAX) has total liabilities worth Skr59.89 Million SEK (≈ $6.45 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore PAX net assets growth trend to track the company's year-over-year net asset growth rate.
Paxman AB - Total Liabilities Trend (2016–2024)
This chart illustrates how Paxman AB's total liabilities have evolved over time, based on quarterly financial data. See Paxman AB (PAX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Paxman AB Competitors by Total Liabilities
The table below lists competitors of Paxman AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Organic Tea Cosmetics Holdings Company Limited
KQ:900300
|
Korea | ₩73.67 Billion |
|
Servotronics Inc
NYSE MKT:SVT
|
USA | $13.01 Million |
|
China Electric Manufacturing Corp
TW:1611
|
Taiwan | NT$1.28 Billion |
|
vTv Therapeutics Inc
NASDAQ:VTVT
|
USA | $8.85 Million |
|
Inseego Corp
NASDAQ:INSG
|
USA | $109.57 Million |
|
CTW Cayman Class A Ordinary Shares
NASDAQ:CTW
|
USA | $18.85 Million |
|
Torimbia Socimi S.A.
MC:YTRM
|
Spain | €89.87 Million |
|
Acusensus Ltd
AU:ACE
|
Australia | AU$43.22 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Paxman AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Paxman AB market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Paxman AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Paxman AB (2016–2024)
The table below shows the annual total liabilities of Paxman AB from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr63.24 Million ≈ $6.81 Million |
+42.08% |
| 2023-12-31 | Skr44.51 Million ≈ $4.79 Million |
-25.52% |
| 2022-12-31 | Skr59.76 Million ≈ $6.43 Million |
+47.25% |
| 2021-12-31 | Skr40.59 Million ≈ $4.37 Million |
-38.62% |
| 2020-12-31 | Skr66.12 Million ≈ $7.12 Million |
+16.80% |
| 2019-12-31 | Skr56.61 Million ≈ $6.09 Million |
+86.56% |
| 2018-12-31 | Skr30.34 Million ≈ $3.27 Million |
+136.33% |
| 2017-12-31 | Skr12.84 Million ≈ $1.38 Million |
+2.41% |
| 2016-12-31 | Skr12.54 Million ≈ $1.35 Million |
-- |
About Paxman AB
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of … Read more